Back

Emergence of Severe Metastatic Hypervirulent Klebsiella pneumoniae infections in Texas

Alam, J. M.; Ahmed, H.; Hong, T. M.; Garnepudi, K.; Kesavan, R. B.; Jayaraman, G.; Sangster, A.; Curry, D.; Butz, H. A.; Smith, L.; Vowles, M.; Oakeson, K. F.; Young, E. L.; Sarva, S. T.

2021-06-09 respiratory medicine
10.1101/2021.06.08.21257347
Show abstract

BackgroundHypervirulent Klebsiella pneumoniae (hvKp) infections have mainly been described in Asia. Two patients in the age group of 30 to 50 years presented within a two month period to a tertiary referral hospital in Texas with septic shock, hepatic abscess and septic thrombophlebitis. Blood cultures were positive for Klebsiella pneumoniae (isolates 2020CK-00441 and 2021CK-00720 respectively). MethodsWhole genome sequencing was performed using paired-end Illumina MiSeq reads for both isolates. Nanopore sequencing to obtain a closed genome was performed for 2020CK-00441. Results2020CK-00441 belonged to ST23 type while 2021CK-00720 was a ST65 type isolate. Kleborate analyses predicted with high confidence that both the isolates were hvKp. Phylogenetic analyses showed that the two strains are not closely related to each other or to any other known hvKp isolates. Both the isolates had yersiniabactin, colibactin, aerobactin and salmochelin producing loci which likely confer these isolates hvKp phenotype. 2020CK-00441 had a unique pK2044 like plasmid. ConclusionsHvKp strains capable of causing devastating metastatic septic infections have emerged in Texas. These isolates are unique when compared to other hvKp strains of the world. Country wide surveillance and whole genome sequencing of these strains is essential to prevent a major public health emergency in USA.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of Clinical Microbiology
based on 77 papers
Top 0.5%
12.6%
2
PLOS ONE
based on 1737 papers
Top 46%
11.2%
3
Journal of Medical Virology
based on 95 papers
Top 0.9%
7.6%
4
Respiratory Research
based on 10 papers
Top 0.2%
7.6%
5
Scientific Reports
based on 701 papers
Top 31%
5.9%
6
The Lancet Microbe
based on 33 papers
Top 0.2%
4.5%
7
European Respiratory Journal
based on 44 papers
Top 2%
3.0%
50% of probability mass above
8
Journal of Clinical Virology
based on 54 papers
Top 1%
2.8%
9
Frontiers in Molecular Biosciences
based on 10 papers
Top 0.1%
2.8%
10
Emerging Infectious Diseases
based on 84 papers
Top 5%
2.5%
11
Frontiers in Medicine
based on 99 papers
Top 7%
2.5%
12
Microbial Genomics
based on 24 papers
Top 0.6%
2.5%
13
Open Forum Infectious Diseases
based on 124 papers
Top 4%
2.3%
14
BMJ Open Respiratory Research
based on 32 papers
Top 1%
2.3%
15
Microbiology Spectrum
based on 86 papers
Top 1%
1.6%
16
mSystems
based on 16 papers
Top 2%
1.2%
17
eClinicalMedicine
based on 55 papers
Top 4%
0.8%
18
International Journal of Infectious Diseases
based on 115 papers
Top 17%
0.8%
19
ERJ Open Research
based on 36 papers
Top 3%
0.8%
20
Medicine
based on 29 papers
Top 8%
0.8%
21
Annals of Translational Medicine
based on 14 papers
Top 4%
0.8%
22
EMBO Molecular Medicine
based on 15 papers
Top 2%
0.8%
23
The American Journal of Pathology
based on 11 papers
Top 1%
0.7%
24
Clinical and Translational Medicine
based on 11 papers
Top 2%
0.7%
25
Cells
based on 14 papers
Top 2%
0.7%
26
Frontiers in Genetics
based on 32 papers
Top 6%
0.7%
27
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 2%
0.7%
28
Antimicrobial Agents and Chemotherapy
based on 17 papers
Top 2%
0.7%